J7601 Ensifentrine inh 3 mg

Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 2 units per day (practitioner), rationale: Prescribing Information